Shopping Cart 0
Cart Subtotal
USD 0

Personal Genome Diagnostics Inc - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Personal Genome Diagnostics Inc (PGD) is a genomic solution provider. The company develops next-generation sequencing and proprietary algorithms to identify alterations in complex cancer genomes. It provides a portfolio of regulated tissue-based and liquid biopsy genomic products for laboratories. PGD offers high-throughput next-generation sequencing and proprietary algorithms to identify alterations in complex cancer genomes. It provides custom solutions such as cancer whole genome analysis, cancer genome germline analysis, sample preparation and sequencing, data interpretation and analysis, cancer bioinformatic analysis and ctDNA analyses, among others. The company caters to academics, biotechnology and pharmaceutical companies, and contract research organizations. PGD is headquartered in Baltimore, Maryland, the US.

Personal Genome Diagnostics Inc-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Personal Genome Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Personal Genome Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Personal Genome Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Personal Genome Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

Personal Genome Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Personal Genome Diagnostics Inc, Medical Equipment, Deal Details 11

Venture Financing 11

Personal Genome Diagnostics Raises USD75 Million in Series B Financing 11

Personal Genome Diagnostics Raises USD65.4 Million in Venture Financing 13

Personal Genome Diagnostics Raises USD4.3 Million in Venture Financing 14

Personal Genome Diagnostics Raises USD 2.8 Million In Venture Financing 15

Personal Genome Diagnostics Raises USD 2 Million In Venture Financing 16

Private Equity 17

Innovatus Capital Partners to Invest up to USD42 Million in Personal Genome Diagnostics 17

Partnerships 18

Personal Genome Diagnostics Enters into Licensing Agreement with Memorial Sloan Kettering Cancer 18

Personal Genome Diagnostics Enters into Licensing Agreement with Johns Hopkins University 19

Personal Genome Diagnostics Enters into Licensing Agreement with Human Longevity 20

QIAGEN Enters Into Licensing Agreement With Personal Genome Diagnostics 21

Personal Genome Diagnostics Enters into Agreement Five Prime Therapeutics 22

Personal Genome Diagnostics Enters into Co-Development Agreement with Illumina 23

Cure Forward Enters into Agreement with Personal Genome Diagnostics 24

Personal Genome Diagnostics And MolecularMD Enter Into Agreement For Genomic Testing Services 25

Personal Genome Diagnostics Enters Into Co-Development Agreement With Blueprint Medicines For Novel Kinase Targets 26

Personal Genome Enters Into Licensing Agreement With Johns Hopkins University 27

Personal Genome Diagnostics Inc-Key Competitors 28

Personal Genome Diagnostics Inc-Key Employees 29

Personal Genome Diagnostics Inc-Locations And Subsidiaries 30

Head Office 30

Recent Developments 31

Corporate Communications 31

Jan 17, 2017: Personal Genome Diagnostics Adds James Lewis as Senior Vice President of Corporate Development 31

Product News 32

Dec 14, 2017: Liquid Biopsy Results Differed Substantially Between Two Providers 32

Jun 02, 2017: Personal Genome Diagnostics Highlights its Patent-Pending Microsatellite Instability Testing Technology as FDA Approves Keytruda for MSI Tumors 33

Mar 30, 2017: Personal Genome Diagnostics Announces AACR Annual Meeting 2017 Presentations and Awards 34

Jan 04, 2017: Personal Genome Diagnostics ImmunoSELECT Technology Demonstrates How Resistance to Checkpoint Blockade Therapy Evolves in Cancer Discovery Study 35

Other Significant Developments 36

Sep 05, 2018: Machine learning approach by Personal Genome Diagnostics outperforms existing mutation detection methods according to study in Science Translational Medicine 36

Nov 10, 2017: U.S. Dept. of Veterans Affairs Renews and Expands Cancer Testing Contract with Personal Genome Diagnostics 37

Appendix 38

Methodology 38

About GlobalData 38

Contact Us 38

Disclaimer 38


List Of Figure

List of Figures

Personal Genome Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Personal Genome Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Personal Genome Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Personal Genome Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Personal Genome Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Personal Genome Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

Personal Genome Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Personal Genome Diagnostics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

Personal Genome Diagnostics Inc, Medical Equipment, Key Facts 2

Personal Genome Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Personal Genome Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Personal Genome Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Personal Genome Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Personal Genome Diagnostics Inc, Deals By Market, 2012 to YTD 2018 8

Personal Genome Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Personal Genome Diagnostics Raises USD75 Million in Series B Financing 11

Personal Genome Diagnostics Raises USD65.4 Million in Venture Financing 13

Personal Genome Diagnostics Raises USD4.3 Million in Venture Financing 14

Personal Genome Diagnostics Raises USD 2.8 Million In Venture Financing 15

Personal Genome Diagnostics Raises USD 2 Million In Venture Financing 16

Innovatus Capital Partners to Invest up to USD42 Million in Personal Genome Diagnostics 17

Personal Genome Diagnostics Enters into Licensing Agreement with Memorial Sloan Kettering Cancer 18

Personal Genome Diagnostics Enters into Licensing Agreement with Johns Hopkins University 19

Personal Genome Diagnostics Enters into Licensing Agreement with Human Longevity 20

QIAGEN Enters Into Licensing Agreement With Personal Genome Diagnostics 21

Personal Genome Diagnostics Enters into Agreement Five Prime Therapeutics 22

Personal Genome Diagnostics Enters into Co-Development Agreement with Illumina 23

Cure Forward Enters into Agreement with Personal Genome Diagnostics 24

Personal Genome Diagnostics And MolecularMD Enter Into Agreement For Genomic Testing Services 25

Personal Genome Diagnostics Enters Into Co-Development Agreement With Blueprint Medicines For Novel Kinase Targets 26

Personal Genome Enters Into Licensing Agreement With Johns Hopkins University 27

Personal Genome Diagnostics Inc, Key Competitors 28

Personal Genome Diagnostics Inc, Key Employees 29

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Personal Genome Diagnostics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.